Rilpivirine Impurity 13 | CAS 4102-53-8 - Request Quote
Rilpivirine Impurity 13
| SZ CAT No: | SZ-R029036 |
| CAS No | 4102-53-8 |
| Mol.F. | C8H10IN |
| Mol.Wt. | 247.1 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 138385-59-8 (HCl salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Rilpivirine Impurity 13 is chemically 4-Iodo-2,6-dimethylaniline. Rilpivirine Impurity 13 is supplied with detailed characterization data compliant with regulatory guideline. Rilpivirine Impurity 13 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rilpivirine .
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 4102-53-8
Purchase 4102-53-8
Order 4102-53-8
Enquire 4102-53-8
price of 4102-53-8
4102-53-8 Supplier
4102-53-8 Manufacturer
4102-53-8 Exporter
buy high quality Rilpivirine Impurity 13
Purchase Rilpivirine Impurity 13
Rilpivirine Impurity 13 suppliers
Rilpivirine Impurity 13 manufacturers
Rilpivirine Impurity 13 price
Order Rilpivirine Impurity 13
Enquire Rilpivirine Impurity 13
Rilpivirine Impurity 13 cost
Rilpivirine Impurity 13 Supplier
Rilpivirine Impurity 13 Distributor
Rilpivirine Impurity 13 for Method Validation
Rilpivirine Reference Standard
Rilpivirine Impurity 13 for ANDA Filing
Rilpivirine Impurity 13 for Forced Degradation Studies
Rilpivirine Impurity 13 Identification Standards
Rilpivirine Impurity 13 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


